Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer epigenetics in clinical practice
Verónica Dávalos, Manel Esteller
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 4, pp. 376-424
Open Access | Times Cited: 141

Showing 26-50 of 141 citing articles:

Oxidative stress-mediated epigenetic remodeling, metastatic progression and cell signaling in cancer
Abdul Rehman Phull, Sadia Qamar Arain, Abdul Majid, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 4, pp. 493-507
Closed Access | Times Cited: 5
Research progress and applications of epigenetic biomarkers in cancer
Jianjun Gao, Wujiang Shi, Jiangang Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
Clinical Perspectives in Epitranscriptomics
Eloy Santos-Pujol, Carlos Quero-Dotor, Manel Esteller
Current Opinion in Genetics & Development (2024) Vol. 87, pp. 102209-102209
Open Access | Times Cited: 4
SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2‐Mediated Chromatin Remodeling
Wei Zhang, Xianhui Ruan, Yue Huang, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 4
Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer
Yuanxin Yao, Honghui Lv, M Zhang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 721-734
Closed Access | Times Cited: 4
Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9
Tao Fan, Xiao Chu, Ziqin Deng, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal Potential
Kaiyao Wei, Marie Arlotto, Justin M. Overhulse, et al.
Advanced Science (2025)
Open Access
Histone Modifications and DNA Methylation in Psoriasis: A Cellular Perspective
Jing Pan, Siji Chen, Xianzhen Chen, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Epigene functional diversity: isoform usage, disordered domain content, and variable binding partners
Leroy Bondhus, Aileen A. Nava, Isabelle S. Liu, et al.
Epigenetics & Chromatin (2025) Vol. 18, Iss. 1
Open Access
The technology landscape for detection of DNA methylation in cancer liquid biopsies
Isabelle Neefs, Joe Ibrahim, Marc Peeters, et al.
Epigenetics (2025) Vol. 20, Iss. 1
Open Access
UiO-66 MOFs-Based “Epi-Nano-Sonosensitizer” for Ultrasound-Driven Cascade Immunotherapy against B-Cell Lymphoma
Zhihua Wang, Mingda Han, Yiqiao Wang, et al.
ACS Nano (2025)
Closed Access
Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
Chengdi Wang, Jingwei Li, Jingyao Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Multi-omics analysis of epigenetic dysregulation reveals clinical heterogeneity and evaluates the immunotherapeutic potential of lung adenocarcinoma
Yuqing Ren, Zaoqu Liu, Yi Yue, et al.
Genes & Diseases (2025), pp. 101561-101561
Open Access
A possible role for epigenetics in cancer initiation
Anne‐Marie Martinez, Giacomo Cavalli
Comptes Rendus Biologies (2025) Vol. 348, Iss. G1, pp. 43-53
Open Access
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Epigenetic regulation of stress
Mariam K. Alamoudi, Noura N. Alibrahim, Abdulmonem A. Alsaleh, et al.
Progress in brain research (2025)
Closed Access
Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess
Tsung‐Cheng Yin, Yuyu Liu, Chenwen Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
EXOSC5: A Novel Biomarker for Poor Prognosis in Lung Adenocarcinoma
Jianxun Xu, Zhengwei Zhang, Keyao Han, et al.
Research Square (Research Square) (2025)
Open Access
Exploring the Potential of Precision Medicine in Neuropsychiatry: A Commentary on New Insights for Tailored Treatments Based on Genetic, Environmental, and Lifestyle Factors
Jelena Milić, Milica Vučurović, Dragana Jović, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 371-371
Open Access
Function and regulation of RGS family members in solid tumours: a comprehensive review
Chenglong Yang, Xiaoyuan Zhang, Xiaowen Yang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Epigenomics in aortic dissection: From mechanism to therapeutics
Tao Yan, Gang Li, Yanyan Yang, et al.
Life Sciences (2023) Vol. 335, pp. 122249-122249
Closed Access | Times Cited: 11
Application of deep learning in cancer epigenetics through DNA methylation analysis
Maryam Yassi, Aniruddha Chatterjee, Matthew Parry
Briefings in Bioinformatics (2023) Vol. 24, Iss. 6
Open Access | Times Cited: 11
The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma
Mei Feng, Hao Xu, Wenyuan Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 10
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9

Scroll to top